These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18069451)

  • 41. Pathogenomics: an updated European Research Agenda.
    Demuth A; Aharonowitz Y; Bachmann TT; Blum-Oehler G; Buchrieser C; Covacci A; Dobrindt U; Emödy L; van der Ende A; Ewbank J; Fernández LA; Frosch M; García-Del Portillo F; Gilmore MS; Glaser P; Goebel W; Hasnain SE; Heesemann J; Islam K; Korhonen T; Maiden M; Meyer TF; Montecucco C; Oswald E; Parkhill J; Pucciarelli MG; Ron E; Svanborg C; Uhlin BE; Wai SN; Wehland J; Hacker J
    Infect Genet Evol; 2008 May; 8(3):386-93. PubMed ID: 18321793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New ways to identify novel bacterial antigens for vaccine development.
    Movahedi AR; Hampson DJ
    Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of proteomics in dementia and Alzheimer's disease.
    Zellner M; Veitinger M; Umlauf E
    Acta Neuropathol; 2009 Jul; 118(1):181-95. PubMed ID: 19259691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
    Patel V; Hood BL; Molinolo AA; Lee NH; Conrads TP; Braisted JC; Krizman DB; Veenstra TD; Gutkind JS
    Clin Cancer Res; 2008 Feb; 14(4):1002-14. PubMed ID: 18281532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomic profiling of endothelial cells in human lung cancer.
    Park HJ; Kim BG; Lee SJ; Heo SH; Kim JY; Kwon TH; Lee EB; Ryoo HM; Cho JY
    J Proteome Res; 2008 Mar; 7(3):1138-50. PubMed ID: 18220333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In silico analysis of potential diagnostic targets from Burkholderia pseudomallei.
    Thompson DB; Crandall K; Harding SV; Smither SJ; Kitto GB; Titball RW; Brown KA
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S61-5. PubMed ID: 19121691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomics and disease: opportunities and challenges.
    Kavallaris M; Marshall GM
    Med J Aust; 2005 Jun; 182(11):575-9. PubMed ID: 15938685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteomics in cardiovascular surgery.
    Matt P; Carrel T; White M; Lefkovits I; Van Eyk J
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):210-4. PubMed ID: 17198814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomics Clinical Applications reviews 2012.
    Dunn MJ
    Proteomics Clin Appl; 2012 Jan; 6(1-2):3-5. PubMed ID: 22447694
    [No Abstract]   [Full Text] [Related]  

  • 51. The application of clinical proteomics to cancer and other diseases.
    Clarke W; Zhang Z; Chan DW
    Clin Chem Lab Med; 2003 Dec; 41(12):1562-70. PubMed ID: 14708880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Possibilities and applications of rapid microbiological diagnosis].
    Leinonen M; Viljanen M; Halonen P
    Duodecim; 1985; 101(13):1247-59. PubMed ID: 3896747
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical audit for the need to process blood cultures signalling positive after-hours.
    Morris AJ; Taylor SL; Ikram R; Botes J; Robson J; Chambers I
    Pathology; 2007 Oct; 39(5):531-5. PubMed ID: 17886110
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic markers: progress and potential for cardiovascular disease.
    Gibbons GH; Liew CC; Goodarzi MO; Rotter JI; Hsueh WA; Siragy HM; Pratt R; Dzau VJ
    Circulation; 2004 Jun; 109(25 Suppl 1):IV47-58. PubMed ID: 15226250
    [No Abstract]   [Full Text] [Related]  

  • 55. The predictive value of microbiologic diagnostic tests if asymptomatic carriers are present. Ronny K. Gunnarsson and Jan Lanke, Statistics in Medicine 2002; 21:1773-1785.
    Taube A
    Stat Med; 2003 Apr; 22(7):1201-2. PubMed ID: 12652562
    [No Abstract]   [Full Text] [Related]  

  • 56. [Proteomics as a fundamental tool for subclinical screening, tests verification and assessment of applied therapy].
    Suchkov SV; Gnatenko DA; Kostiushev DS; Krynskiĭ SA; Pal'tsev MA
    Vestn Ross Akad Med Nauk; 2013; (1):65-71. PubMed ID: 23805642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PROTEOMICS - Clinical Applications reviews 2010.
    Proteomics Clin Appl; 2010 Feb; 4(2):113-5. PubMed ID: 21137036
    [No Abstract]   [Full Text] [Related]  

  • 58. [Proteomics, a new challenge for clinical microbiology].
    Pitarch A; Nombela C; Gil C
    Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):489-91. PubMed ID: 20888998
    [No Abstract]   [Full Text] [Related]  

  • 59. Potential applications and limitations of proteomics in the study of neurological disease.
    Kinoshita Y; Uo T; Jayadev S; Garden GA; Conrads TP; Veenstra TD; Morrison RS
    Arch Neurol; 2006 Dec; 63(12):1692-6. PubMed ID: 17172608
    [No Abstract]   [Full Text] [Related]  

  • 60. [Microbiological diagnosis in general practice. What must be considered in tissue sampling].
    MMW Fortschr Med; 2005 May; 147(20):6, 8. PubMed ID: 15957849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.